Geron reported $-28675000 in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Cytokinetics CYTK:US $ -80.55M 58.85M
Genmab GEN:DC 514M 295M
Geron GERN:US $ -28.68M 2.31M
Novartis NOVN:VX 2.56B 671M